市場調查報告書
商品編碼
1284251
到 2028 年的白色生物技術市場預測 - 按產品(生物聚合物、生物燃料、其他產品)、最終用戶(電子和半導體、消費品和服務、其他最終用戶)、地區分列的全球分析White Biotech Market Forecasts to 2028 - Global Analysis By Product (Biopolymers, Biofuels and Other Products), End User (Electronics and Semiconductor, Consumer Goods And Services and Other End Users) and By Geography |
根據Stratistics MRC,2022年全球白色生物技術市場規模將達到2053.8億美元,預計到2028年將達到4321.5億美元,預計年復合增長率為13.2%
科學技術思想的應用構成了生物技術的基礎。 工業生物技術是白色生物技術的別稱。 一種利用□和微生物生產生物基產品的方法,可用於多種行業,包括化學品、生物能源、家庭護理、食品和飼料以及製藥。 新興國家和貧窮國家的最終用戶基本上沒有意識到白色生物技術產品給他們的日常生活帶來的好處以及非生物產品溫室氣體排放的負面影響。
根據總部位於法國的政府間組織國際能源署 (IEA) 分享的一份報告,到 2022 年,全球將生產 450 億升生物柴油,高於 2020 年的 370 億升。
在過去的幾年裡,人們對白色生物技術的應用及其諸多好處有了更好的了解,例如環保、降低製造成本、產生更少的廢物以及最大限度地利用原材料。來自最終用戶的需求在成長。 消費者對綠色化學品的高需求,尤其是在發達國家,迫使製造商採用白色生物技術而不是傳統的化學生產工藝。 此外,近年來,聚合物生產技術的開發,尤其是生物質生產技術的開發,為生化市場創造了有利可圖的機會。
人口增長、農業用地稀缺、土地持有量小以及土壤肥力下降等因素會迅速侵蝕生物作物的生產。 對農作物濫用或不正確施肥也在消耗農田的肥力,耗盡其肥力。 生物作物的價格也因化肥的過度使用而波動,因為產量的不確定性預計將限制市場擴張。 大多數養分目前的養分利用效率仍然很低。 因此,土地肥力下降和生物作物生產受限可能會限制預測期內的市場增長。
全球對生物基和可生物降解聚合物的需求量達到 96 萬噸。 儘管仍處於起步階段,生物塑料行業已成為許多商業行業和應用的基石。 消費者對環保材料的偏好、塑料加工商和復合商對生物塑料的使用增加以及擴大生物塑料優勢的新產品發布預計將推動幾乎所有地區的需求強勁增長。
由於與傳統肥料相比,發達經濟體和新興經濟體對生物肥料的採用率較低,預計全球白色生物技術市場的增長將放緩。 土壤肥力下降和糧食需求增加正在增加對常規肥料的需求。 此外,與傳統燃料相比,生物燃料的採用率較低,預計也將抑制市場擴張。 這是由於生物燃料的不穩定供應以及傳統燃料優於生物燃料的性能。
COVID-19 大流行對白色生物技術市場的製藥行業創新產生了重大影響,表明該領域的市場擴張取得了成功。 消費者對綠色化學品的需求不斷增長,尤其是在北美和歐洲等發達地區,預計將推動製造商使用白色生物技術工藝代替傳統化學品製造。 在預測期內,隨著汽車和消費品行業等各種消費行業在實現其可持續發展目標方面面臨越來越大的壓力,預計對技術的需求將會增加。
由於更嚴格的立法、環境問題和客戶對更可持續產品的需求,生化行業預計將實現利潤豐厚的增長。 因此,多年來,包括家用清潔劑製造商在內的清潔劑製造商通過降低溫度、減少包裝和增加擬議產品中生物基成分的數量來減少碳足跡。
由於在生物製藥生產中越來越多地使用技術,尤其是不能通過化學合成製造的用於癌症治療的抗體,預計醫療保健行業在預測期內將以最快的複合年增長率增長。 此外,該方法中使用的□能夠製備難以合成的手性分子和中間體,例如活性藥物成分 (API)。
由於生物技術增強型食品配料的可用性,預計亞太地區在預測期內將佔據最大的市場份額。 在這種技術中,玩家為他們附近的企業提供資金。 它還限制了中國生物技術和製藥行業的發展,因為產品污染會改變效力並降低產品質量。
預計北美在預測期內的複合年增長率最高。 隨著人類和牲畜數量的增長,對食物的需求也在增長。 城市侵占農業用地給土地利用帶來壓力。 這種國際趨勢為生物技術促進農業生產提供了機會。
2022 年 3 月,愛爾蘭上市食品公司 Kerry Group plc 將以 1.348 億美元(1.37 億歐元)的價格收購 c-Lecta 92% 的已發行股本。 此次收購將加速凱愛瑞在□工程、發酵和生物工藝開發方面的創新能力。
2021 年 3 月,巴斯夫風險投資公司 (BVC) 投資了位於中國杭州的工業合成生物技術公司 Bota Biosciences Ltd。 該公司開發了下一代生物技術平台,能夠以可持續和經濟的方式生產高價值產品,用於廣泛的工業應用,包括甜味劑、維生素、個人護理和農藥保護產品。
According to Stratistics MRC, the Global White Biotech Market is accounted for $205.38 billion in 2022 and is expected to reach $432.15 billion by 2028 growing at a CAGR of 13.2% during the forecast period. The use of scientific and technical ideas forms the foundation of biotechnology. Industrial biotechnology is another name for white biotechnology. In order to produce bio-based products that may be used in a variety of industries, including chemicals, bio-energy, home care, food and feed, and pharmaceuticals, this method makes use of enzymes and microorganisms. The advantages of white biotech products in everyday life and the negative consequences of greenhouse gas emissions from non-biological products are not commonly known to end users in emerging and impoverished nations.
According to a report shared by the International Energy Agency (IEA), a France-based autonomous intergovernmental organization, by 2022, 45 billion liters of biodiesel will be produced worldwide, up from 37 billion in 2020.
White biotechnology has seen a growth in demand from end users over the past few years as a result of a growing understanding of its uses and numerous benefits, which include eco-friendliness, reduced manufacturing costs, little waste formation, and maximum raw material utilisation. Consumer demand for green chemicals, especially in developed nations, is forcing manufacturers to adopt white biotechnology rather than conventional chemical production processes. Furthermore, the development of polymer production technology, notably from biomass, has created profitable opportunities in the biochemical market over the past few years.
The production status of bio crops may soon be lost due to factors such as the growing population, the scarcity of agricultural land, small landholdings, and declining soil fertility. The fertility of agricultural areas also decreased due to the misuse and incorrect application of fertilisers to crops, which has led to the depletion of that fertility. Because there is uncertainty over the production yield, which is expected to restrict market expansion, the prices of bio-crops have also fluctuated due to excessive fertiliser use. The current degree of nutrient-use efficiency is still quite low for the majority of nutrients. As a result, falling land fertility is limiting the production of bio crops, which could restrict the market's growth throughout the projection period.
Global demand for bio-based and biodegradable polymers reached 960,000 metric tonnes. The bioplastics industry, though still in its infancy, has established itself as a cornerstone in a number of commercial industries and applications. Due to consumer preferences for eco-friendly materials, a growth in the usage of bioplastics by plastic processors and compounders, and the launch of new products that expand the benefits of bioplastics, demand is anticipated to rise significantly in almost all geographic areas.
The global white biotechnology market is anticipated to experience slower growth due to lower adoption of biofertilizers compared to traditional fertilisers in both developed and emerging economies. Increased desire for conventional fertilisers is a result of declining soil fertility and growing food demand. Additionally, it is anticipated that lesser adoption of biofuels relative to conventional fuels will also restrain market expansion. This is caused by the variable supply of biofuels and the superior performance of conventional fuels over biofuels.
The COVID-19 pandemic had a huge impact on the pharmaceutical industry's innovation in the white biotechnology market, which suggests a successful market expansion in the sector. The growing consumer demand for green chemicals, particularly in developed regions like North America and Europe, is expected to drive manufacturers to use white biotechnology processes rather than conventional chemical manufacturing. Over the projection period, it is anticipated that the demand for technology would increase due to the growing pressure on various consumer industries, such as the automotive and consumer goods sectors, to fulfil the sustainability targets.
The biochemicals segment is estimated to have a lucrative growth, as a result of stricter laws, environmental concerns, and customer demand for more sustainable products. As a result, producers of cleaning products including those for the home have been decreasing their carbon footprints for years by lowering suggested product temperatures, reducing packaging, and increasing the number of bio-based components.
The healthcare segment is anticipated to witness the fastest CAGR growth during the forecast period, due to increasing technological use in the production of biopharmaceuticals, particularly antibodies for cancer treatment that cannot be produced through chemical synthesis. Additionally, the creation of chiral molecules and other challenging-to-synthesize intermediates, including active pharmaceutical ingredients (API), is made possible by the enzymes used in this method.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the availability of biotechnologically altered food ingredients. In this approach, players contribute money to nearby companies. Additionally, product contamination results in variable potency and poor product quality, which restrict the growth of the Chinese biotech and pharmaceutical industry.
North America is projected to have the highest CAGR over the forecast period. Food demand is rising due to an increase in both human and livestock populations. As urban areas are encroaching on agricultural grounds, it puts pressure on how land is used. These international trends provide biotechnology with the opportunity to boost agricultural production.
Some of the key players profiled in the White Biotech Market include Global Bioenergies, Solazyme, Borregaard, BioAmber., Fermentalg, Amyris, Codexis, Deinove, Novozymes, Metabolic Explorer, Evolva, Gevo, Kerry Group plc and BASF SE.
In March 2022, Kerry Group plc (Kerry), an Ireland-based public food company, acquired 92% of the issued share capital of c-Lecta for $134.8 million (€ 137M). With this acquisition, Kerry's innovative capabilities in enzyme engineering, fermentation, and bioprocess development will be accelerated.
In March 2021, BASF Venture Capital (BVC) invested in Bota Biosciences Ltd (Bota Bio), an industrial synthetic biotech company located in Hangzhou, China, which develops next-generation biotechnology platforms, enabling sustainable and economical production of high-value products for a broad array of industrial applications, like sweeteners, vitamins, personal care, or crop protection products.